Startseite
Impressum
Datenschutz
 
 
  GLOSSARY
 

Per protocol analysis

 
  SPOT ON
 

Surrogate endpoints to evaluate benefit in oncology

 
  THERAPY FROM A CRITICAL VIEWPOINT
 

POET-COPD: tiotropium superior to salmeterol

 
  a-t READER'S QUESTIONS AND COMMENTS
 

SHIFT study: reevaluation of ivabradine necessary?

UCB: the same with differences

 
  IN BRIEF
 

Diuretic strategies for decompensated heart failure

Long-acting risperidone in schizophrenia

Lavender oil (LASEA) and the German Medical Products Advertising Act

Medical journals: influence of funding sources on the content

Cave: vfa brochure - ideal pharmaceutical world for teenagers

 
  CURRENT ADR NETWORK REPORT
 

Angioedema due to saxagliptin (ONGLYZA)?

Nightmares, depression with dronedarone (MULTAQ)

 
  SIDE EFFECTS
 

Increased cardiovascular mortality with olmesartan

 
  e a-t IN THE INTERNET
 

Lavender oil (LASEA): Spitzner comments on the a-t article

 
© arznei-telegramm 4/2011